Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Article Information
vol. 43 no. 5 1085-1093
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 30, 2019
- Accepted February 13, 2020
- Published in print April 20, 2020.
- Published online ahead of print March 5, 2020.
Article Versions
- Previous version (March 5, 2020 - 08:52).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
Author Information
- W. Timothy Garvey1⇑,
- Andreas L. Birkenfeld2,3,4,
- Dror Dicker5,6,
- Geltrude Mingrone4,7,8,
- Sue D. Pedersen9,
- Altynai Satylganova10,
- Dorthe Skovgaard10,
- Danny Sugimoto11,
- Camilla Jensen10 and
- Ofri Mosenzon12
- 1Department of Nutrition Sciences, The University of Alabama at Birmingham and the Birmingham VA Medical Center, Birmingham, AL
- 2Department of Diabetology, Endocrinology, and Nephrology, Eberhard Karls University Tübingen, Tübingen, Germany
- 3Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany
- 4Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, U.K.
- 5Internal Medicine D, Hasharon Hospital, Rabin Medical Center, Petah Tikva, Israel
- 6Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
- 7Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
- 8Università Cattolica del Sacro Cuore, Rome, Italy
- 9C-ENDO Diabetes and Endocrinology Clinic, Calgary, Alberta, Canada
- 10Novo Nordisk A/S, Søborg, Denmark
- 11Cedar Crosse Research Center, Chicago, IL
- 12Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
- Corresponding author: W. Timothy Garvey, garveyt{at}uab.edu
Statistics from Altmetric.com
Article usage
In this Issue
May 2020, 43(5)
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
